
CAS 1224925-76-1
:Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
3 produits concernés.
Granisetron-d3
CAS :Formule :C18H21D3N4OCouleur et forme :White To Off-White SolidMasse moléculaire :315.44Granisetron-d3
CAS :Produit contrôléApplications Granisetron-d3 is the labeled analogue of Granisetron (G780000), a specific serotonin (5HT3) receptor antagonist. Used as an antiemetic.
References Kilpatrick, G.J., et al.: Nature, 330, 746 (1987); Durig, T., et al.: J. Pharm. Sci., 86, 1092 (1997); Yuasa, H., et al.: Chem. Pharm. Bull., 44, 1361 (1996)Formule :C18D3H21N4OCouleur et forme :NeatMasse moléculaire :315.431-(Methyl-d3)-N-[(3-endo)-9-methyl-9-azabicyclo[3.3.1]non-3-yl]-1H-indazole-3-carboxamide
CAS :Produit contrôlé1-(Methyl-d3)-N-[(3-endo)-9-methyl-9-azabicyclo[3.3.1]non-3-yl]-1H-indazole-3-carboxamide is a potent protein kinase inhibitor with anticancer properties. It has been shown to inhibit the growth of cancer cells by blocking the cell cycle and inducing apoptosis. This medicinal compound has been found to be effective in inhibiting various human kinases, including those involved in tumor growth and proliferation. In Chinese hamster ovary cells, this inhibitor has been shown to have a strong effect on the phosphorylation of key proteins involved in cell signaling pathways. The compound also exhibits selectivity towards specific kinases, making it a promising candidate for targeted cancer therapies. Overall, 1-(Methyl-d3)-N-[(3-endo)-9-methyl-9-azabicyclo[3.3.1]non-3-yl]-1H-indazole-Formule :C18H24N4ODegré de pureté :Min. 95%Masse moléculaire :315.4 g/mol


